| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
potassium inwardly rectifying channel subfamily J member 6 | 0.615 | 0.692 | 0.54 |
|
disease | 0.410 | None | 1.000 | 2 | 96 | 2011 | 2013 | ||||||||
|
long intergenic non-protein coding RNA 2694 | 0.780 | 0.308 | 1.7E-02 |
|
disease | 0.410 | None | 1.000 | 1 | 18 | 2013 | 2013 | ||||||||
|
alcohol dehydrogenase 1B (class I), beta polypeptide | 0.502 | 0.846 | 9.9E-07 |
|
disease | 0.700 | None | 1.000 | 8 | 12 | 1994 | 2019 | ||||||||
|
alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.547 | 0.731 |
|
disease | 0.700 | None | 1.000 | 6 | 5 | 1991 | 2019 | |||||||||
|
alcohol dehydrogenase 4 (class II), pi polypeptide | 0.641 | 0.462 | 8.1E-07 |
|
disease | 0.500 | None | 1.000 | 4 | 2 | 1994 | 2019 | ||||||||
|
FTO alpha-ketoglutarate dependent dioxygenase | 0.486 | 0.885 | 8.4E-08 |
|
disease | 0.430 | None | 1.000 | 3 | 2 | 2011 | 2019 | ||||||||
|
aldehyde dehydrogenase 2 family member | 0.457 | 0.885 | 3.4E-10 |
|
disease | 0.700 | None | 1.000 | 7 | 1 | 1991 | 2019 | ||||||||
|
KIAA0040 | 0.931 | 0.154 | 0.20 |
|
disease | 0.420 | None | 1.000 | 3 | 1 | 2011 | 2015 | ||||||||
|
PBX/knotted 1 homeobox 2 | 0.743 | 0.500 | 0.99 |
|
disease | 0.420 | None | 1.000 | 2 | 1 | 2011 | 2015 | ||||||||
|
serine incorporator 2 | 0.792 | 0.192 | 3.9E-13 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
neurexin 3 | 0.656 | 0.615 | 1.00 |
|
disease | 0.310 | None | 1.000 | 1 | 1 | 2007 | 2007 | ||||||||
|
thrombospondin type 1 domain containing 7B | 0.890 | 0.154 | 2.6E-19 |
|
disease | 0.410 | None | 1.000 | 1 | 1 | 2011 | 2011 | ||||||||
|
catenin alpha 2 | 0.663 | 0.500 | 0.43 |
|
disease | 0.420 | None | 1.000 | 1 | 1 | 2014 | 2019 | ||||||||
|
prodynorphin | 0.535 | 0.577 | 1.7E-04 |
|
disease | 0.600 | None | 0.800 | 7 | 0 | 1997 | 2018 | ||||||||
|
solute carrier family 6 member 4 | 0.429 | 0.808 | 0.25 |
|
disease | 0.600 | None | 0.800 | 7 | 0 | 1998 | 2020 | ||||||||
|
synuclein alpha | 0.427 | 0.885 | 0.88 |
|
disease | 0.580 | None | 1.000 | 6 | 0 | 2004 | 2014 | ||||||||
|
opioid receptor mu 1 | 0.457 | 0.808 | 7.9E-11 |
|
disease | 0.600 | None | 0.800 | 6 | 0 | 1998 | 2019 | ||||||||
|
gamma-aminobutyric acid type A receptor subunit alpha2 | 0.641 | 0.346 | 1.00 |
|
disease | 0.700 | None | 0.800 | 6 | 0 | 2004 | 2017 | ||||||||
|
cytochrome P450 family 2 subfamily E member 1 | 0.459 | 0.885 | 8.1E-09 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 1995 | 2018 | ||||||||
|
neuropeptide Y | 0.447 | 0.846 | 0.14 |
|
disease | 0.600 | None | 1.000 | 6 | 0 | 2001 | 2017 | ||||||||
|
cholecystokinin A receptor | 0.615 | 0.500 | 4.0E-03 |
|
disease | 0.530 | None | 0.800 | 6 | 0 | 1998 | 2005 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 2B | 0.510 | 0.692 | 1.00 |
|
disease | 0.380 | None | 0.800 | 5 | 0 | 2003 | 2017 | ||||||||
|
dopamine beta-hydroxylase | 0.511 | 0.846 | 3.3E-10 |
|
disease | 0.400 | None | 1.000 | 5 | 0 | 1981 | 2014 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
disease | 0.400 | None | 0.400 | 5 | 0 | 2004 | 2020 | ||||||||
|
ankyrin repeat and kinase domain containing 1 | 0.604 | 0.462 | 7.4E-12 |
|
disease | 0.400 | None | 0.800 | 5 | 0 | 2004 | 2017 |